Clarivate Posts 3Q Adjusted EPS of 21 Cents
CLVT is trading near its 52-week low of $1.42 (9.2% above the low).
Summary
Clarivate reported third-quarter adjusted EPS of 21 cents, alongside revenue of $567.9M and a net loss of $80.8M, or a loss of 13 cents per share. The bar is low: Q2 revenue fell 5.5% to $587.3M and the quarter carried a $221.7M goodwill impairment tied to the Life Sciences & Healthcare unit. That unit is now gone — the $600M divestiture to Altaris closed in early October, and the pro forma filed October 13 shows a leaner continuing business. Adjusted EPS strips out the impairment and deal costs, so 21 cents says little about how the remaining subscription business is performing; revenue and organic growth are the numbers that matter. The company guided to 2026 revenue of $1.97B-$1.99B and fourth-quarter revenue of $490M-$510M. The stock trades near $1.55 with a market cap just above $1B, so any surprise in the top line moves it hard.
At the time of this announcement, CLVT was trading at $1.55 on NYSE in the Technology sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $1.42 to $3.87. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.